Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta E Beolgrade currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. The current prosecution docket is highly concentrated, focusing on a single technical advancement. This singular focus allows for a dedicated strategy but lacks the breadth of a larger portfolio.
MICHAEL V MELLER is the busiest examiner for the institute, holding 1 busiest examiner pending office action. This action represents the entirety of the 1 pending office action for the organization. As a result, the institute's current patent office interactions are focused on this one individual. The outcome of the institute's current legal efforts is dependent on the decisions of this specific examiner.
The presence of 1 distinct art unit indicates a specific technical focus for the pending application. With 1 distinct examiner involved, there is no variation in examination approach across the current portfolio. Practitioners should focus on the specific requirements and preferences of MICHAEL V MELLER to resolve the 1 pending office action. Success in the art unit will require a precise and technically sound response to the examiner's findings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MELLER, MICHAEL V | 1 | 47.4% | +28.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286095 | Aristotelia chilensis EXTRACTS FOR TREATING FUNGAL INFECTIONS | MELLER, MICHAEL V | 13d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286095 | Aristotelia chilensis EXTRACTS FOR TREATING FUNGAL INFECTIONS | MELLER, MICHAEL V | 13d |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286095 | Aristotelia chilensis EXTRACTS FOR TREATING FUNGAL INFECTIONS | MELLER, MICHAEL V | 1655 | §101§102§103 | Non-Final OA | 13d | Pending | Oct 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta E Beolgrade has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Michael V Meller has the most, with 1 of Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta E Beolgrade's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.